
Academic Journal
Q2Pharmacogenomics and Personalized Medicine
About Pharmacogenomics and Personalized Medicine
Pharmacogenomics and Personalized Medicine is a scholarly journal published by Dove Medical Press Ltd. SCImago 2025 lists it in Q2, with an SJR of 0.73 and H-index of 44.
Coverage: 2009-2026. Research categories: Pharmacology (Q2); Molecular Medicine (Q3).
Open-access policies and author information
Reported in the official DOAJ public CSV snapshot (2026-09-01), downloaded 2026-10-03. Record updated 2026-04-27. This snapshot does not establish today’s listing status or fee quotation.
Publisher policy links recorded by DOAJ
- Aims and scope ↗
- Editorial board ↗
- Instructions for authors ↗
- Peer-review policy ↗
- Publication fees ↗
- Fee waivers ↗
- Licence terms ↗
- Copyright policy ↗
- Preservation policy ↗
Source: DOAJ journal record. Journal metadata is distributed by DOAJ under CC0. Confirm current fees, tax, eligibility and waiver terms with the publisher.
Source-backed journal facts
Topics in published research
Pharmacogenetics and Drug Metabolism; Ferroptosis and cancer prognosis; Cancer-related molecular mechanisms research; Genetic Associations and Epidemiology; Drug Transport and Resistance Mechanisms; Antiplatelet Therapy and Cardiovascular Diseases.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Clinical Outcomes of an ApoE Genotype-Guided Lipid-Lowering Strategy in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention
Siliang Han, Yichao Zhang, Zhe Wang, Fanchang Kong et al.
2026-09 · DOI: 10.2147/pgpm.s608221Exploring Genetic Clues in Kikuchi-Fujimoto Disease: A Three-Generation Study
Cheryl Weiqi Tan, Gayatiri Raveentheran, Khadijah Rafi'ee, Lena Das et al.
2026-09 · DOI: 10.2147/pgpm.s602876Five VEGFA Polymorphisms and Bleeding During Warfarin Therapy in a Saudi Population: An Exploratory Retrospective Cohort Study
Jasmine Holail, Reem Mobarak, Bandar Al-Ghamdi, Said El Shamieh et al.
2026-09 · DOI: 10.2147/pgpm.s619780Whole-Exome and Whole-Genome Sequencing of Candidate Pharmacogenomic and Schizophrenia-Related Genes in Sudanese Families with Schizophrenia
Safa A Abdalla, Azza Saeed, Lamees Ahmed, Safa Abuswar et al.
2026-09 · DOI: 10.2147/pgpm.s616976Low Frequency of HLA-B*15:02 in Northwest China: Implications for Carbamazepine-Induced Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Screening Strategies
Xu Wang, Ping Yang, Feng Rao, Longnan Wang et al.
2026-08 · DOI: 10.2147/pgpm.s621616Cost-Effectiveness of Pharmacogenomics-Guided Treatment in Cardiovascular Disease: An Umbrella Review
Slobodan M Janković, Miloš Milosavljević, Ivana Stević, Adna Ašić et al.
2026-08 · DOI: 10.2147/pgpm.s613319Association Between UGT1A9 rs13418420 Polymorphism and Propofol Induction Characteristics in Chinese Female Patients Undergoing Brief Gynecological Procedures
Xuanwei Huang, Yuxin Tan, Qingling Gu, Liang Zhang et al.
2026-08 · DOI: 10.2147/pgpm.s611673Implementing Pharmacogenomics in Contemporary Hospital Care: Insights from Multidisciplinary Knowledge Exchange
Safeera Y Hussainy, Rachel Conyers, Paul A James, Marliese Alexander et al.
2026-08 · DOI: 10.2147/pgpm.s606574Molecular Epidemiology of Thalassemia in University Town, Chongqing: Spectrum of Pathogenic Variants and Implications for Carrier Screening
Wei Cai, Yi Liang, Li-Na Kang, Ya-Qian Jin et al.
2026-07 · DOI: 10.2147/pgpm.s608098Anaplastic Lymphoma Kinase Positive Aggressive Adult Lung Primary Inflammatory Myofibroblastoma Tumor: A Case and Literature Review
Panfeng Xu, Shan Lu
2026-07 · DOI: 10.2147/pgpm.s591506Comparative Analysis of SLCO1B1 Gene Polymorphisms in Dyslipidemic and Normolipidemic Patients with Type 2 Diabetes Mellitus Residing at High Altitude
Yong-Hong Ma, Zong-Hong Ji, Chun-Na Han, Sheng-Hua Ma et al.
2026-07 · DOI: 10.2147/pgpm.s593658Population-Based Assessment of Phenoconversion Potential in Switzerland: A Claims Data Study of Key Drug-Metabolizing Enzymes and Transporters
Marietta Roth, Aline Bencastro, Christoph Meier, Carola Huber et al.
2026-05 · DOI: 10.2147/pgpm.s586384Construction and Validation of Multi-Omics Predictive Models for Colorectal Cancer Using Machine-Learning Approaches
Zhenhuan Lu, Xiaowen Li, Zhiping Liang, Xiaocong Zhang et al.
2026-04 · DOI: 10.2147/pgpm.s566928Massive Hepatocellular Carcinoma with Insufficient Future Liver Remnant Achieved Complete Response After Two-Stage Hepatectomy Combined with Hepatic Arterial Infusion Chemotherapy and Lenvatinib-sintilimab: A Case Report
Ruoxiang Xu, Mingrui Zhang, Zhiming Zeng, Yongguang Wei et al.
2026-04 · DOI: 10.2147/pgpm.s578577NAT2 Acetylation Phenotypes in India: A Narrative Review of Personalized TB Therapy
Nikhat Khan, Manjari Jonnalagadda, Ravindra Kumar, Aparup Das et al.
2026-03 · DOI: 10.2147/pgpm.s568037Bioinformatic Identification and Preliminary Validation of TP53, TGFB1, and NFE2L2 as Potential Ferroptosis-Related Regulators in Pancreatic Adenocarcinoma
Shouying Li, Chunfang Zhang, Shengxiang Lv, Zhimei Zhang et al.
2026-02 · DOI: 10.2147/pgpm.s562602Post-Translational Modifications of Histones and Non-Histones in Liver Disease and Traditional Chinese Medicine Treatment: A Narrative Review
Zhuohua Xie, Yanting Deng, Xinru Zhang, Jieyi Chen et al.
2026-02 · DOI: 10.2147/pgpm.s555701Clinical Outcomes of Osimertinib Combined with Platinum-Based Chemotherapy in EGFR-Mutant Non-Small Cell Lung Cancer: A Retrospective Study
Ruixue Han, Xin Yu
2026-02 · DOI: 10.2147/pgpm.s566952Managing Refractory Hypertension: A Case Study Exploring the Influence of ACE and ACTN3 Gene Polymorphisms
Benedikt Gasser, Alain Dössegger, Martin Flück
2025-12 · DOI: 10.2147/pgpm.s528939Case Report: Successful Surgical Resection of PVTT Vp4 Hepatocellular Carcinoma Following Hepatic Arterial Infusion Chemotherapy Combined with Cadonilimab Plus Donafenib
Sizhi Chen, Yongguang Wei, Xiwen Liao, Chengkun Yang et al.
2025-12 · DOI: 10.2147/pgpm.s555061Reviews
Community Reviews
Version History
October 4, 2026 at 9:07 pm
October 2, 2026